A recent study conducted by researchers from Seattle-based University of Washington and Durham, N.C.-based Duke University found a strong association between the use of fall-risk increasing drugs and ...

Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Aug. 22, 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying molecule is as sneaky as its inventors ... COPD and BPD ...

Amgen and AstraZeneca have hopes for their asthma drug Tezspire as a potential COPD treatment. Additionally, Regeneron and Sanofi have a second COPD candidate in IL-33 inhibitor itepekimab ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol ...

Of the hundreds of drugs that entered the U.S. market in 2024, GoodRx has named 19 of them as the most notable. Note: The chronological list does not ... approved for COPD on Sept.

A commercial court here temporarily restrained a city-based electric wires and cable manufacturer from selling its products under the brand name Wipro, after the multinational company alleged ...

UÔHTdà¤Õþð(Jjï s/ rÒê PµHȼ`õǯ?ÿü÷ß pýÿƒÑd¶Xmv‡Óåöx}~ÿii½ù& ¶Ç’Ý >®ùÜ]ê ®.ŽHiüG¥báxMbÔÝÀ h C©ÊItÅŽ2;Êügþ¬ÿýlVÂ5 )- [ À¸s1„îô7ßù ...

SEATTLE, Dec 23 (Reuters) - Boeing (BA.N), opens new tab CEO Kelly Ortberg has tapped Ann Schmidt to be chief communications and brand officer in the latest executive appointment since Ortberg ...

A COPD Action and Management ... plan should include the names of your medicines, how much to take and when to take it. A COPD action plan is divided into three zones: green, yellow and red. The dose ...

Circassia Pharmaceuticals, a British company with U.S. headquarters in Morrisville, plans to acquire the full U.S. commercial rights to Tudorza, a treatment for chronic obstructive pulmonary disease ...